期刊文献+

血清TSH、FT4、TPOAb联合检测在妊娠早期甲状腺功能筛查中应用分析 被引量:1

Screening for Thyroid Function in Early Pregnancy: Application of Serum TSH, FT4, TPOAb
下载PDF
导出
摘要 目的分析抗甲状腺过氧化物酶自身抗体(TPOAb)、游离甲状腺素(FT4)、促甲状腺素(TSH)联合检测在妊娠早期甲状腺功能筛查中的应用价值。方法选取2015年4月~2016年4月在我院进行妊娠诊断和产前检查的60例妊娠早期妇女作为观察组,选取同期在我院进行健康体检的70例非妊娠妇女作为对照组。检测所有妇女血清TPOAb、FT4、FT3和TSH,比较两组妇女甲状腺功能检查结果和甲状腺疾病发生情况。结果对照组TPOAb明显低于观察组,FT4和TSH明显高于观察组,差异有统计学意义(P<0.05);对照组甲状腺疾病总发生率(12.86%)明显低于观察组(33.33%),差异有统计学意义(P<0.05)。结论血清TSH、FT4、TPOAb联合检测在妊娠早期甲状腺功能筛查中具有重要的作用,有助于及时发现和治疗甲状腺功能异常情况,降低甲状腺疾病发生率,利于母婴健康。 Objective To analyze the application value of semm TSH, FT4, TPOAb on screening for tJiyroid function in early pregnancy. Metiiods: In total, 60 women with early pregnancy were examined in our hospital from April 2015 to April 2016 as test group, while 70 healthy examinees were selected as control group. The serum TPOAb, FT4, FT3, and TSH were detected for comparing two groups in thyroid function and thyroid diseases. Results: (1) The semm TPOAb in control group was significantly lower than that in test group. However, FT4, and TSH in control group were significantly higher than those in test group (P 〈 0.05). (2) The total incidence o f thyroid diseases in control group (12.86%) was significandy lower than that in test group (33.33%) (P 〈 0.05). Condusions: Screening the serum TSH, FT4 and TPOAb has important evidence for determination of thyroid function screening in early pregjiancy, which can help to find thyroid disorders and reduce the rate of thyroid diseases, to promote maternal and child health.
作者 胜瑞刚
出处 《西藏医药》 2017年第4期8-10,共3页 Tibetan Medicine
关键词 妊娠早期 甲状腺功能筛查 应用价值 Early Pregnancy Thyroid Function Screening Application Value
  • 相关文献

参考文献8

二级参考文献89

  • 1王晓红,何鸣.甲状腺功能检测对妊娠合并原发性甲减诊断价值探讨[J].实用临床医药杂志,2006,10(2):92-93. 被引量:14
  • 2单忠艳,滕卫平.甲状腺疾病与妊娠[J].国际内分泌代谢杂志,2006,26(5):295-302. 被引量:104
  • 3中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:846
  • 4谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 5Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and manage- ment of thyroid disease during pregnancy and postpartum[J]. Thyroid,2011,21(10) 1081-1125.
  • 6Cooper DS. Antithyroid drugs in the management of patients with Gravesp diseasean evidence-based approach to therapeutic contro- versies[J]. J Clin Endocrinol Metab, 2003,88 (8) : 3474-3481.
  • 7Drews K, Seremak-Mrozikiewicz A. The optimal treatment of thy roid gland function disturbances during pregnancy [ J ]. Curt Pharm Biotechnol, 2011,12(5) : 774-780.
  • 8Baloch Z, Carayon P, Conte-Devoix B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease[J].Thyroid, 2003, 13(1): 3-126.
  • 9Boas M, Forman JL, Juul A, et al. Narrow intra individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women[J]. Eur J Endocrinol, 2009, 161(6): 903-910.
  • 10Cotzias C, Wong S J, Taylor E, et al. A study to establish gestation specific reference intervals for thyroid function tests in normal singleton pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2008, 137(1): 61-66.

共引文献98

同被引文献14

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部